Results of a Phase II Study of Short-Course Accelerated Radiation Therapy (SHARON) for Multiple Brain Metastases

Luciana Caravatta, Francesco Deodato, Marica Ferro, Gabriella Macchia, Mariangela Massaccesi, Savino Cilla, Rosa Tambaro, Samantha Mignogna, Gilbert D A Padula, Michela Musacchio, Mariano Flocco, Giampaolo Cantore, Andrea Scapati, Solomon Bogale, Mario Balducci, Vincenzo Valentini, Numa Cellini, Alessio G. Morganti

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objectives: To assess the effectiveness of a SHort-course Accelerated RadiatiON therapy (SHARON) in the treatment of patients with multiple brain metastases. Materials and Methods: A phase II clinical trial was designed. Eligibility criteria included patients with at least 3 brain metastases or metastatic disease in >3 organ systems, and Eastern Cooperative Oncology Group performance status of ≤3. Fifty patients were treated with whole brain radiotherapy at 18 Gy (4.5 Gy per fraction) in 2 days with a twice daily fractionation. The primary endpoint was the assessment of efficacy in terms of overall survival. Results: Characteristics of the 50 enrolled patients were: male/female: 24/26; median age: 65 years (range, 45 to 80 y). Eastern Cooperative Oncology Group performance status was

Original languageEnglish
Pages (from-to)395-400
Number of pages6
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume38
Issue number4
DOIs
Publication statusPublished - Aug 6 2015

Fingerprint

Radiotherapy
Neoplasm Metastasis
Brain
Phase II Clinical Trials
Survival
Therapeutics

Keywords

  • brain metastases
  • palliative care
  • quality of life
  • radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Medicine(all)

Cite this

Results of a Phase II Study of Short-Course Accelerated Radiation Therapy (SHARON) for Multiple Brain Metastases. / Caravatta, Luciana; Deodato, Francesco; Ferro, Marica; Macchia, Gabriella; Massaccesi, Mariangela; Cilla, Savino; Tambaro, Rosa; Mignogna, Samantha; Padula, Gilbert D A; Musacchio, Michela; Flocco, Mariano; Cantore, Giampaolo; Scapati, Andrea; Bogale, Solomon; Balducci, Mario; Valentini, Vincenzo; Cellini, Numa; Morganti, Alessio G.

In: American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 38, No. 4, 06.08.2015, p. 395-400.

Research output: Contribution to journalArticle

Caravatta, L, Deodato, F, Ferro, M, Macchia, G, Massaccesi, M, Cilla, S, Tambaro, R, Mignogna, S, Padula, GDA, Musacchio, M, Flocco, M, Cantore, G, Scapati, A, Bogale, S, Balducci, M, Valentini, V, Cellini, N & Morganti, AG 2015, 'Results of a Phase II Study of Short-Course Accelerated Radiation Therapy (SHARON) for Multiple Brain Metastases', American Journal of Clinical Oncology: Cancer Clinical Trials, vol. 38, no. 4, pp. 395-400. https://doi.org/10.1097/COC.0b013e3182a0e826
Caravatta, Luciana ; Deodato, Francesco ; Ferro, Marica ; Macchia, Gabriella ; Massaccesi, Mariangela ; Cilla, Savino ; Tambaro, Rosa ; Mignogna, Samantha ; Padula, Gilbert D A ; Musacchio, Michela ; Flocco, Mariano ; Cantore, Giampaolo ; Scapati, Andrea ; Bogale, Solomon ; Balducci, Mario ; Valentini, Vincenzo ; Cellini, Numa ; Morganti, Alessio G. / Results of a Phase II Study of Short-Course Accelerated Radiation Therapy (SHARON) for Multiple Brain Metastases. In: American Journal of Clinical Oncology: Cancer Clinical Trials. 2015 ; Vol. 38, No. 4. pp. 395-400.
@article{831a986aa9f0423282652468ee9f84ab,
title = "Results of a Phase II Study of Short-Course Accelerated Radiation Therapy (SHARON) for Multiple Brain Metastases",
abstract = "Objectives: To assess the effectiveness of a SHort-course Accelerated RadiatiON therapy (SHARON) in the treatment of patients with multiple brain metastases. Materials and Methods: A phase II clinical trial was designed. Eligibility criteria included patients with at least 3 brain metastases or metastatic disease in >3 organ systems, and Eastern Cooperative Oncology Group performance status of ≤3. Fifty patients were treated with whole brain radiotherapy at 18 Gy (4.5 Gy per fraction) in 2 days with a twice daily fractionation. The primary endpoint was the assessment of efficacy in terms of overall survival. Results: Characteristics of the 50 enrolled patients were: male/female: 24/26; median age: 65 years (range, 45 to 80 y). Eastern Cooperative Oncology Group performance status was",
keywords = "brain metastases, palliative care, quality of life, radiotherapy",
author = "Luciana Caravatta and Francesco Deodato and Marica Ferro and Gabriella Macchia and Mariangela Massaccesi and Savino Cilla and Rosa Tambaro and Samantha Mignogna and Padula, {Gilbert D A} and Michela Musacchio and Mariano Flocco and Giampaolo Cantore and Andrea Scapati and Solomon Bogale and Mario Balducci and Vincenzo Valentini and Numa Cellini and Morganti, {Alessio G.}",
year = "2015",
month = "8",
day = "6",
doi = "10.1097/COC.0b013e3182a0e826",
language = "English",
volume = "38",
pages = "395--400",
journal = "American Journal of Clinical Oncology",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Results of a Phase II Study of Short-Course Accelerated Radiation Therapy (SHARON) for Multiple Brain Metastases

AU - Caravatta, Luciana

AU - Deodato, Francesco

AU - Ferro, Marica

AU - Macchia, Gabriella

AU - Massaccesi, Mariangela

AU - Cilla, Savino

AU - Tambaro, Rosa

AU - Mignogna, Samantha

AU - Padula, Gilbert D A

AU - Musacchio, Michela

AU - Flocco, Mariano

AU - Cantore, Giampaolo

AU - Scapati, Andrea

AU - Bogale, Solomon

AU - Balducci, Mario

AU - Valentini, Vincenzo

AU - Cellini, Numa

AU - Morganti, Alessio G.

PY - 2015/8/6

Y1 - 2015/8/6

N2 - Objectives: To assess the effectiveness of a SHort-course Accelerated RadiatiON therapy (SHARON) in the treatment of patients with multiple brain metastases. Materials and Methods: A phase II clinical trial was designed. Eligibility criteria included patients with at least 3 brain metastases or metastatic disease in >3 organ systems, and Eastern Cooperative Oncology Group performance status of ≤3. Fifty patients were treated with whole brain radiotherapy at 18 Gy (4.5 Gy per fraction) in 2 days with a twice daily fractionation. The primary endpoint was the assessment of efficacy in terms of overall survival. Results: Characteristics of the 50 enrolled patients were: male/female: 24/26; median age: 65 years (range, 45 to 80 y). Eastern Cooperative Oncology Group performance status was

AB - Objectives: To assess the effectiveness of a SHort-course Accelerated RadiatiON therapy (SHARON) in the treatment of patients with multiple brain metastases. Materials and Methods: A phase II clinical trial was designed. Eligibility criteria included patients with at least 3 brain metastases or metastatic disease in >3 organ systems, and Eastern Cooperative Oncology Group performance status of ≤3. Fifty patients were treated with whole brain radiotherapy at 18 Gy (4.5 Gy per fraction) in 2 days with a twice daily fractionation. The primary endpoint was the assessment of efficacy in terms of overall survival. Results: Characteristics of the 50 enrolled patients were: male/female: 24/26; median age: 65 years (range, 45 to 80 y). Eastern Cooperative Oncology Group performance status was

KW - brain metastases

KW - palliative care

KW - quality of life

KW - radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=84938567814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938567814&partnerID=8YFLogxK

U2 - 10.1097/COC.0b013e3182a0e826

DO - 10.1097/COC.0b013e3182a0e826

M3 - Article

C2 - 26214084

AN - SCOPUS:84938567814

VL - 38

SP - 395

EP - 400

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 4

ER -